SALT LAKE CITY – Dec. 2, 2025 – bioMérieux, a global leader in in vitro diagnostics, received nine 2025 IMV ServiceTrak™ Clinical Laboratory Awards for excellence in Immunoassay Analyzers, ID/AST Systems, Molecular Diagnostics and Blood Culture Systems, underscoring bioMérieux’s dedication to delivering industry-leading diagnostic solutions and exceptional service to laboratories and healthcare providers worldwide. These awards include:
- Immunoassay Analyzers
- Best System Performance - highest overall system functionality
- Best OEM Service Performance - highest satisfaction with OEM service and support.
- ID/AST Systems
- Best Customer Satisfaction - highest likelihood customers will purchase again
- Best System Performance - highest overall system functionality
- Best OEM Service Performance - highest satisfaction with OEM service and support
- Blood Culture Systems
- Best Customer Satisfaction - highest likelihood customers will purchase again
- Best System Performance - highest overall system functionality
- Best OEM Service Performance - highest satisfaction with OEM service and support
- Molecular Diagnostics
- Best System Performance - highest overall system functionality
This recognition follows bioMérieux’s earlier achievements announced at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Conference in August, where the company was awarded Clinical Laboratory Awards for Immunoassay - Best System Performance, and Immunoassay - Best Service. Collectively, these nine accolades reflect bioMérieux’s deep-rooted culture of excellence and its leadership in advancing laboratory diagnostics for improved patient care.
“At bioMérieux, customer centricity is a mindset that drives every part of our organization,” said David Machenaud, Vice President, U.S. Customer Support Operations, “Being honored with IMV ServiceTrak™ awards for eight consecutive years is a direct result of the passion and dedication of our teams. From those behind the scenes to our colleagues in the field, we are united by a shared commitment to service excellence. These awards are a testament to our mission to support better health outcomes.”
IMV, part of Science and Medicine Group, is a market research and business intelligence provider to the laboratory diagnostic industry. The 2025 IMV ServiceTrak™ Clinical Laboratory Awards are based on extensive customer surveys measuring satisfaction with service, system performance, training, and overall experience with diagnostic equipment vendors.
For more information about bioMérieux’s award-winning diagnostic solutions, please visit www.biomerieux.com or contact media@biomerieux.com.
ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached €4 billion, with over 93% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP